Advances and challenges in targeting FGFR signalling in cancer

IS Babina, NC Turner - Nature Reviews Cancer, 2017 - nature.com
Fibroblast growth factors (FGFs) and their receptors (FGFRs) regulate numerous cellular
processes. Deregulation of FGFR signalling is observed in a subset of many cancers …

Targeting FGFR signaling in cancer

M Touat, E Ileana, S Postel-Vinay, F André… - Clinical cancer …, 2015 - AACR
The fibroblast growth factor signaling pathway (FGFR signaling) is an evolutionary
conserved signaling cascade that regulates several basic biologic processes, including …

Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF/FGFR Aberrations: A Phase I Dose-Expansion Study

F Meric-Bernstam, R Bahleda, C Hierro, M Sanson… - Cancer discovery, 2022 - AACR
Futibatinib, a highly selective, irreversible FGFR1–4 inhibitor, was evaluated in a large
multihistology phase I dose-expansion trial that enrolled 197 patients with advanced solid …

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

YK Chae, K Ranganath, PS Hammerman… - …, 2016 - pmc.ncbi.nlm.nih.gov
The fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) is a tyrosine kinase
signaling pathway that has a fundamental role in many biologic processes including …

FGFR-TKI resistance in cancer: current status and perspectives

S Yue, Y Li, X Chen, J Wang, M Li, Y Chen… - Journal of hematology & …, 2021 - Springer
Fibroblast growth factor receptors (FGFRs) play key roles in promoting the proliferation,
differentiation, and migration of cancer cell. Inactivation of FGFRs by tyrosine kinase …

[HTML][HTML] FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis

M Katoh - International journal of molecular medicine, 2016 - spandidos-publications.com
Abstract Fibroblast growth factor (FGF) 2, FGF4, FGF7 and FGF20 are representative
paracrine FGFs binding to heparan-sulfate proteoglycan and fibroblast growth factor …

FGFR a promising druggable target in cancer: Molecular biology and new drugs

R Porta, R Borea, A Coelho, S Khan, A Araújo… - Critical reviews in …, 2017 - Elsevier
Abstract Introduction The Fibroblast Growth Factor Receptor (FGFR) family consists of
Tyrosine Kinase Receptors (TKR) involved in several biological functions. Recently …

Feedback activation of STAT3 as a cancer drug-resistance mechanism

C Zhao, H Li, HJ Lin, S Yang, J Lin, G Liang - Trends in pharmacological …, 2016 - cell.com
Signal transducer and activator of transcription 3 (STAT3) plays crucial roles in several
cellular processes such as cell proliferation and survival, and has been found to be …

EGFR inhibition potentiates FGFR inhibitor therapy and overcomes resistance in FGFR2 fusion–positive cholangiocarcinoma

Q Wu, Y Zhen, L Shi, P Vu, P Greninger, R Adil… - Cancer discovery, 2022 - AACR
FGFR inhibitors are approved for the treatment of advanced cholangiocarcinoma harboring
FGFR2 fusions. However, the response rate is moderate, and resistance emerges rapidly …

Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis

M Li, F Liu, F Zhang, W Zhou, X Jiang, Y Yang, K Qu… - Gut, 2019 - gut.bmj.com
Objectives Patients with gallbladder carcinoma (GBC) lack effective treatment methods
largely due to the inadequacy of both molecular characterisation and potential therapeutic …